Congenital muscular dystrophies

Area of Science:

• Neurology
• Genetics
• Pediatrics

Background:

• Congenital muscular dystrophies (CMDs) are a diverse set of inherited neuromuscular disorders.
• These conditions manifest with muscle weakness and a dystrophic muscle biopsy pattern from birth or early infancy.

Purpose of the Study:

• To review common forms of CMDs, including laminin α-2 deficiency, Ullrich CMD, fukutin-related proteinopathy, rigid spine syndrome, and α-dystroglycan glycosylation disorders.
• To discuss clinical presentations, genetic defects, and diagnostic approaches for CMDs.
• To highlight the importance of multidisciplinary care for managing CMDs.

Main Methods:

• Literature review of congenital muscular dystrophies.
• Synthesis of information on clinical findings and genetic defects.
• Discussion of diagnostic work-up and management strategies.

Main Results:

• Identified key CMD subtypes: laminin α-2 deficiency, Ullrich CMD, fukutin-related proteinopathy, rigid spine syndrome, and α-dystroglycan glycosylation disorders.
• Highlighted association of some CMDs (e.g., glycosylation disorders) with central nervous system abnormalities like lissencephaly and ocular anomalies.
• Emphasized the lack of curative treatments but the importance of symptomatic care.

Conclusions:

• CMDs are heterogeneous genetic disorders requiring accurate diagnosis based on clinical and genetic findings.
• Management focuses on multidisciplinary symptomatic care to enhance patient quality of life.
• Further research is needed for potential curative therapies.